News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
864,894 Results
Type
Article (87627)
Company Profile (823)
Press Release (776427)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233144)
Career Advice (4142)
Deals (39825)
Drug Delivery (141)
Drug Development (91310)
Employer Resources (203)
FDA (18314)
Job Trends (17412)
News (397582)
Policy (39935)
Tag
Academia (3006)
Academic (2)
Accelerated approval (20)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (153)
Alzheimer's disease (1714)
Antibody-drug conjugate (ADC) (282)
Approvals (18378)
Artificial intelligence (546)
Autoimmune disease (120)
Automation (31)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (175)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (54)
Breast cancer (543)
Cancer (4357)
Cardiovascular disease (386)
Career advice (3563)
Career pathing (39)
CAR-T (264)
CDC (57)
Cell therapy (728)
Cervical cancer (34)
Clinical research (76107)
Collaboration (1507)
Company closure (4)
Compensation (1003)
Complete response letters (64)
COVID-19 (2967)
CRISPR (92)
C-suite (673)
Cystic fibrosis (144)
Data (5294)
Decentralized trials (2)
Denatured (66)
Depression (123)
Diabetes (480)
Diagnostics (7130)
Digital health (41)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (256)
Drug pricing (200)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99817)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (133946)
Executive appointments (1004)
FDA (21005)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1355)
Gene editing (195)
Generative AI (53)
Gene therapy (591)
GLP-1 (1058)
Government (5403)
Grass and pollen (8)
Guidances (377)
Healthcare (20941)
HIV (54)
Huntington's disease (41)
IgA nephropathy (76)
Immunology and inflammation (268)
Immuno-oncology (27)
Indications (64)
Infectious disease (3226)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (106)
Intellectual property (205)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (37)
Legal (10152)
Liver cancer (94)
Longevity (14)
Lung cancer (617)
Lymphoma (304)
Machine learning (33)
Management (66)
Manufacturing (697)
MASH (161)
Medical device (14944)
Medtech (14980)
Mergers & acquisitions (22834)
Metabolic disorders (1248)
Multiple sclerosis (145)
NASH (23)
Neurodegenerative disease (259)
Neuropsychiatric disorders (76)
Neuroscience (2842)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (596)
Opinion (320)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (189)
Parkinson's disease (254)
Partnered (32)
Patents (445)
Patient recruitment (358)
Peanut (58)
People (66476)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23476)
Phase II (33033)
Phase III (24899)
Pipeline (3433)
Policy (310)
Postmarket research (3554)
Preclinical (10610)
Press Release (72)
Prostate cancer (215)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (730)
Real estate (7431)
Recruiting (80)
Regulatory (28287)
Reports (65)
Research institute (2707)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (79)
Schizophrenia (144)
Series A (222)
Series B (167)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1075)
Venture capital (74)
Weight loss (417)
Women's health (68)
Worklife (21)
Date
Today (128)
Last 7 days (729)
Last 30 days (3880)
Last 365 days (33412)
2025 (30430)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1287)
Alabama (83)
Alaska (7)
Arizona (316)
Arkansas (14)
Asia (51155)
Australia (8999)
California (10375)
Canada (3042)
China (986)
Colorado (439)
Connecticut (468)
Delaware (299)
Europe (117662)
Florida (1519)
Georgia (336)
Hawaii (3)
Idaho (68)
Illinois (848)
India (59)
Indiana (503)
Iowa (20)
Japan (348)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1365)
Massachusetts (7721)
Michigan (330)
Minnesota (606)
Mississippi (6)
Missouri (129)
Montana (34)
Nebraska (26)
Nevada (112)
New Hampshire (81)
New Jersey (2847)
New Mexico (32)
New York (2778)
North Carolina (1493)
North Dakota (10)
Northern California (4840)
Ohio (318)
Oklahoma (22)
Oregon (51)
Pennsylvania (2128)
Puerto Rico (20)
Rhode Island (46)
South America (1656)
South Carolina (56)
South Dakota (1)
Southern California (3969)
Tennessee (159)
Texas (1624)
United States (37894)
Utah (310)
Vermont (1)
Virginia (263)
Washington D.C. (85)
Washington State (872)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
There are 864,894 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T
The drugmaker’s dominance of the obesity market is fueling predictions that years of growth lie ahead.
November 20, 2025
·
5 min read
·
Nick Paul Taylor
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.
November 20, 2025
·
1 min read
·
Tristan Manalac
Layoff Tracker
Ensoma Clinic-Bound At Half The Workforce, Cites ‘Financial Discipline’
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 20, 2025
·
90 min read
·
BioSpace Editorial Staff
Lung cancer
Bayer Wins Accelerated Lung Cancer Approval for Kinase Inhibitor
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.
November 20, 2025
·
1 min read
·
Tristan Manalac
Approvals
FDA Hands Regeneron Two Eylea HD Nods in One Day
The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of high-dose Eylea despite outstanding manufacturing concerns.
November 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cognizant selected by CEPI to transform enterprise architecture and core ERP operations
November 20, 2025
·
2 min read
Press Releases
Concept Life Sciences Presents New Data Advancing Neuroinflammation and Neurodegeneration Research at Neuroscience 2025
November 20, 2025
·
4 min read
Press Releases
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
November 20, 2025
·
9 min read
Press Releases
BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform
November 20, 2025
·
3 min read
Press Releases
IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive Director, Strengthening its Board of Directors
November 20, 2025
·
3 min read
1 of 86,490
Next
